First-line chemotherapy with 5-FU and platinum for advanced and recurrent cancer of the cervix: A phase II study

Journal of Obstetrics and Gynaecology

Volumn 23, Issue 4, 2003, Pages 422-425

  Ghaemmaghami, Fatemeh ^a   Behtash, N ^a   Yarandi, F ^a   Moosavi, A ^a   Modares, M ^a   Toogeh, G ^a   Khanafshar, N ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; DEXAMETHASONE; FLUOROURACIL; FUROSEMIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; METOCLOPRAMIDE;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ANEMIA; ARTICLE; BOLUS INJECTION; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; DRUG EFFICACY; ERYTHROCYTE TRANSFUSION; FEMALE; FEVER; GRANULOCYTOPENIA; GYNECOLOGIC CANCER; HUMAN; KIDNEY FAILURE; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; NAUSEA; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENT CANCER; SQUAMOUS CELL CARCINOMA; THROMBOCYTOPENIA; TREATMENT OUTCOME; UTERINE CERVIX CANCER; VOMITING;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, SQUAMOUS CELL; CISPLATIN; FEMALE; FLUOROURACIL; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 0042164860     PISSN: 01443615     EISSN: None     Source Type: Journal    
DOI: 10.1080/0144361031000120969     Document Type: Article

References (18)

1. Alberts D.S., Kronmal R., Baker L.H., Stock-Novack D.L., Surwit E.A., Boutselis J.G. and Hannigan E.V. (1987) Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: a southwest oncology group study. Journal of Clinical Oncology, 5, 1791-1795.
2. Alberts D.S., Garcia D. and Mason-Iiddil N. (1998) Cisplatin in advanced cancer of the cervix: an update. Seminars in Oncology, 18 (Supplement 3), 11-24.
3. Beaupain R. and Dionet C. (1985) Effects of combined treatments of cis-diammine dichloroplatinum II, 5-FU, and x-rays on growth of human cancer nodules maintained in continuous organotypic culture. Cancer Research, 45, 3150-3154.
4. Bonomi P., Blessing J., Ball H., Hanjani P. and DiSaia P.J. (1989) A phase II evaluation of cis and 5-FU in patients with advanced squamous cell carcinoma of the cervix: a gynaecologic oncology group study. Gynecologic Oncology, 34, 357-359.
5. Chiara S., Consoli R., Falcone A., Bruzzone M., Foglia G., Ragni N. and Conte P.F. (1988) Cisplatin and 5-fluorouracil in advanced and recurrent cervical cancer. Tumori, 74, 471-474.
6. Decker D.A., Derlichman A., Jacobs J., Hoschner J., Kinzie J., Loh J.J., Weaver A. and Al-Sarraf M. (1983) Adjuvant chemotherapy with cis-diamine dichloroplatinum II and 120-hour infusion 5FU in stage III, IV squamous cell carcinoma of the head and neck. Cancer, 51, 1353-1355.
7. Kaern J., Trope C., Abeler V., Iversen T. and Kjorstad K. (1990) A phase II study of 5-FU/cis in recurrent cervical cancer. Acta Oncologica, 29, 25-28.
8. Kish J.A., Ensley J.F., Jacobs J., Weaver A., Cummings G. and Al-Sarraf M. (1985) A randomized trial of cisplatin + 5-Fu infusion and cis + 5-FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck. Cancer, 56, 2740-2744.
9. Kish J., Weaver A., Jacobs J., Cummings G. and Al-Sarraf M. (1984) Cisplatin and 5-FU infusion in patient with recurrent and disseminated epidermoid cancer of the head and neck. Cancer, 53, 1819-1824.
10. Omura G., Blessing J., Yordan E., Valea F. and Vaccaiello L. (1996) A randomized trial of cisplatin versus cisplatin + mitolactol versus cisplatin + ifosfamide in advanced squamous carcinoma of the cervix by the gynaecologic oncologic group. Gynecologic Oncology, 63, 120-122.
11. Rowland K.M., Taylor S.G., Spiers A.S., DeConti R.C., O'Donnell M.R., Showel J., Stott P.B., Milner L.M. and Marsh J.C. (1986) Cisplatin and 5-FU infusion chemotherapy in advanced, recurrent cancer of the head and neck: an eastern cooperative oncology group pilot study. Cancer Treatment and Research, 70, 461-464.
12. Sankaranarayanan R., Wesley R., Somanathan T., Dhakad N., Shyamalakumary B., Amma N.S., Parkin D.M. and Nair M.K. (1998) Visual inspection of the utrine cervix after the application of acetic acid in the detection of cervical carcinoma and its precursors. Cancer, 83, 2150-2156.
13. Schabel F.M., Trader M.W., Laster W.R., Corbett T.H. and Griswold D.P. (1979) cis-diammine dichloroplatinum II aombination chemotherapy and cross-resistance studies with tumors of mice. Cancer Treatment and Research, 63, 1459-1473.
14. Teichers B.A., Cucchi A., Lee J.B., Flatou J.L., Rosowsky A. and Frei E. (1986) Alkylating agents: in vitro studies of cross-resistance pattern in human cell line. Cancer Research, 46, 4379-4383.
15. Thigpen T., Vance R.B. and Khansur T. (1995) The platinum compounds and paclitaxel in the management of carcinomas of the endometrium and the uterine cervix. Seminars in Oncology, 22 (Supplement 12), 67-72.
16. Trudeau M., Seymour R., Stanimir G. (2000) A phase II trial of mitomycine, ifosfamide and cisplatin in recurrent carcinoma of cervix. International Journal of Gynecological Cancer, 10, 2070-2111.
17. Wade J.L., Richman G.M., Senekjian E. (1984) Objective response in advanced carcinoma of the cervix using cis-platinum and infusion 5-flourouracil (5-FU) chemotherapy. Proceedings of the American Society of Clinical Oncology, 3, 172.
18. Weiss G.R., Green S., Hannigan E.V., Boutselis J.G., Surwit E.A., Wallace D.L. and Alberts D.S. (1990) A phase II trial of cisplatin and 5-FU with allopurinol for recurrent or metastatic carcinoma of the uterine cervix: a southwest oncology group trial. Gynecologic Oncology, 37, 354-358.